Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients
Abdel-Azeez, H., Eldeeb, S., Atef, D., Abd elfatah, A., Kamel, L. (2024). Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients. EKB Journal Management System, 30(6), 2465-2474. doi: 10.21608/zumj.2024.280851.3304
Hala A. Abdel-Azeez; Sahar Ahmed Mahmoud Mahmoud Eldeeb; Dina M. Atef; Azza H. Abd elfatah; Lamiaa M. Kamel. "Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients". EKB Journal Management System, 30, 6, 2024, 2465-2474. doi: 10.21608/zumj.2024.280851.3304
Abdel-Azeez, H., Eldeeb, S., Atef, D., Abd elfatah, A., Kamel, L. (2024). 'Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients', EKB Journal Management System, 30(6), pp. 2465-2474. doi: 10.21608/zumj.2024.280851.3304
Abdel-Azeez, H., Eldeeb, S., Atef, D., Abd elfatah, A., Kamel, L. Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients. EKB Journal Management System, 2024; 30(6): 2465-2474. doi: 10.21608/zumj.2024.280851.3304